VS Digital Health software vs drug fees

How do VSDH software fees differ from drug fees?

VS Digital Health — commonly known as VSDH — charges platform economics separately from pharmacy wholesale: public materials describe annual white-label licensing, revenue share on bookings and pharmacy orders, and VSDHOne state licenses with per-order platform fees. Drug cost comes from partner-gated wholesale catalog pricing inside ConnectRxCare or the digital pharmacy portal. vsdigitalhealth.com does not publish dollar amounts for either layer — so total cost of ownership requires separating software fees from drug fees inside your partner agreement.

This page explains how to split VSDH platform fees from wholesale drug cost for an honest TCO comparison — and how Fizy Health discloses one facilitation fee at checkout.

Proudly Partnered With

Why separating software from drug fees matters

Clinic COGS should reflect drug cost — what you pay for the vial — not platform software you need to access the catalog. VSDH blends both: you pay annual licensing and revenue share to use the white-label stack, then wholesale for medications through the branded pharmacy. If software fees are amortized incorrectly or revenue share is treated as COGS, margin looks better or worse than reality. An honest comparison separates platform TCO from per-vial drug landed cost.

VSDH software fee categories to map separately

Annual white-label licensing: covers consumer apps, telemedicine modules, medical directorship access, and branded pharmacy portal — a fixed platform cost regardless of order volume.

Revenue share on bookings: telehealth and scheduling revenue share per public partner announcements — hits when patients book consults through the VSDH stack.

Revenue share on pharmacy orders: a percentage of pharmacy order revenue per the same announcements — scales with medication volume and can exceed licensing cost at scale.

VSDHOne fees: state-specific licenses and per-order platform charges for D2C launch per Hydreight public materials — a different software path from core white-label.

Map each line to operating expense or pass-through, not COGS, unless your agreement explicitly bundles platform into wholesale.

VSDH drug fee categories to map to COGS

Wholesale per-vial catalog pricing: the drug line inside the partner portal — should be your COGS numerator for patient pricing.

Shipping and fulfillment: may be bundled into wholesale or billed separately by the branded pharmacy — confirm before modeling landed cost.

Payment processing: confirm pass-through vs markup on pharmacy payments.

Fizy Health comparison: free to join, $0/mo plus pass-through pricing and 9% facilitation, resolved per-vial 503A cost as COGS on each catalog line, one disclosed facilitation fee at checkout as the only platform charge on orders — no annual licensing, no revenue share.

Bundle software and drug in a white-label agreement — or separate COGS from one facilitation fee?

VSDH fits if

VSDH

You budget platform licensing and revenue share separately from wholesale COGS.

  • You launch a D2C brand and treat VSDH software fees as platform overhead, wholesale as COGS.
  • You will itemize both layers in your partner agreement before modeling patient program margin.
  • The full white-label stack — apps, telemedicine, pharmacy — justifies layered software economics.
Consider Fizy Health if

Fizy Health

You want drug cost as COGS and one named platform fee at checkout.

  • You need per-vial 503A cost clean on your COGS line without revenue share mixed in.
  • You want platform cost as one disclosed facilitation fee — not annual licensing plus revenue share.
  • You batch clinic orders without white-label software fees gating access to the catalog.
FAQ

What clinics ask about VSDH software vs drug fees.

  • Software

    What software fees does VSDH charge?

    Public materials describe annual white-label licensing, revenue share on bookings and pharmacy orders, and VSDHOne state licenses with per-order fees. Dollar amounts are agreement-specific.

  • Drug

    Where do VSDH drug fees appear?

    Wholesale per-vial catalog pricing appears in ConnectRxCare or the digital pharmacy portal after partner onboarding. Shipping may be bundled or separate.

  • COGS

    Should revenue share go on my COGS line?

    Generally no — revenue share is platform economics, not drug cost. Model it as operating expense or pass-through separately from per-vial wholesale COGS.

  • TCO

    How do I compare total VSDH cost of ownership?

    Sum annual licensing, expected revenue share at your projected volume, and all-in per-vial landed cost on your top SKUs. Compare that TCO to pass-through alternatives on the same SKU list.

  • Fizy Health

    How does Fizy Health separate software from drug fees?

    Per-vial 503A cost is the drug line on catalog and cart. One disclosed facilitation fee at checkout is the platform charge. No annual licensing or revenue share on orders.

  • Telehealth

    Are telehealth consult fees separate from drug fees on VSDH?

    Yes structurally. Revenue share on bookings covers consult/scheduling revenue; pharmacy revenue share covers medication orders. Confirm percentages for each in your agreement.

Sources reviewed June 2026

  • VS Digital Health public website (vsdigitalhealth.com), reviewed June 2026.
  • Victory Square Technologies / VSDH partner press releases (GlobeNewswire, March 2022).
  • Hydreight Technologies VSDHOne materials (2024–2026).
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

Clean COGS line. One disclosed platform fee.

See per-vial 503A drug cost separate from facilitation fee on your top SKUs. Free to start.